Nobel Laureate, Other Experts Hail WHO Effort On Medicines R&D Framework 22/05/2012 by William New, Intellectual Property Watch 1 Comment The annual World Health Assembly being held this week has a rare chance to achieve a breakthrough on health research for the global poor if it can agree to move forward on a proposed convention, proponents said at a recent meeting.
WIPO Committee On Law Of Patents Walks A Fine Line 22/05/2012 by Catherine Saez, Intellectual Property Watch Leave a Comment The law of patents is being discussed this week at the World Intellectual Property Organization with a focus on the potentially difficult issues of limitations and exceptions, high quality patents, and patents related to public health.
WHO Director Chan Opens Annual Assembly With Optimism, Despite Economic Woes 21/05/2012 by Rachel Marusak Hermann, Intellectual Property Watch 2 Comments World Health Organization Director General Margaret Chan today opened the annual assembly of the UN agency’s member states with a positive outlook on the future of public health. At a time of economic uncertainty, she called on countries to be efficient in their spending, to take ownership of the health of their people, and to look toward innovative health solutions.
India’s Generics-Big Pharma Battle Drops Drug Prices, Raises Legal Debate 20/05/2012 by Patralekha Chatterjee for Intellectual Property Watch 11 Comments The escalating battle between Big Pharma and India’s generic drug manufacturers is pushing down medicine prices in one of the world’s fastest growing pharmaceutical markets.
Drug Safety Needs Global Cooperation Of Drug Regulators, Officials Say 19/05/2012 by Catherine Saez, Intellectual Property Watch Leave a Comment On the eve of the World Health Assembly, the permanent mission of Brazil organised an informal meeting on sanitary regulation and how to improve cooperation among drug regulatory agencies. Major stakeholders were invited to present challenges and ongoing efforts to improve global quality, safety and efficacy of medical products.
US Licensing Experts: Innovation Is Still Happening, Let’s Help It Along 18/05/2012 by William New, Intellectual Property Watch Leave a Comment BOSTON – Early stage innovation is still strong in the United States, but parties need to work better together and address bottlenecks in the middle stages, a panel of university and private sector experts said this week. Meanwhile, the president of global biotechnology company Genzyme said the industry is not in crisis and the company is hopeful about its recent merger with Sanofi.
After Sharp Concerns, Cooperation Prevails On UNCTAD’s Mandate For Next Four Years 16/05/2012 by Catherine Saez, Intellectual Property Watch Leave a Comment After the thirteenth quadrennial session of the United Nations body focusing on trade and development, which was to set its mandate for the next four years, delegates reached consensus and avoided major pitfalls, according to several developed and developing country sources. The governments also worked out differences on UNCTAD’s mandate for work on intellectual property rights.
DNDi Backs WHO ‘Neglected Patients’ R&D Treaty 11/05/2012 by Intellectual Property Watch Leave a Comment The Drugs for Neglected Diseases initiative (DNDi) has released a policy brief in support of the proposed R&D convention to be considered at the upcoming World Health Assembly.
New IFPMA-Backed Report On R&D For Diseases In Developing Countries 10/05/2012 by Intellectual Property Watch Leave a Comment With the launch of a new report concerning research and development for diseases predominately afflicting developing countries, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) today convened a panel of public health specialists to discuss the findings.
German Ministry Advises Developing Countries Not To Sign ACTA 08/05/2012 by Monika Ermert for Intellectual Property Watch 7 Comments Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) advises developing countries against signing the Anti-Counterfeiting Trade Agreement, BMZ official Frank Schmiedchen said during a meeting of the Committee of Petitions of the German Parliament today.